Published in J Vis Exp on April 25, 2012
Platelet serotonin transporter function predicts default-mode network activity. PLoS One (2014) 0.83
The power of using functional fMRI on small rodents to study brain pharmacology and disease. Front Pharmacol (2015) 0.80
Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage (2004) 49.54
Neurophysiological investigation of the basis of the fMRI signal. Nature (2001) 23.94
Bayesian analysis of neuroimaging data in FSL. Neuroimage (2008) 9.10
Brain hemodynamic changes mediated by dopamine receptors: Role of the cerebral microvasculature in dopamine-mediated neurovascular coupling. Neuroimage (2006) 1.89
A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: application to pharmacological MRI. Neuroimage (2006) 1.85
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging. J Neurosci (2004) 1.35
Serotonin in the regulation of brain microcirculation. Prog Neurobiol (1996) 1.30
Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls. Neuroimage (2010) 1.28
Neuronal effects of acute citalopram detected by pharmacoMRI. Psychopharmacology (Berl) (2005) 1.14
In vivo mapping of functional connectivity in neurotransmitter systems using pharmacological MRI. Neuroimage (2006) 1.10
Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine. Neuropsychopharmacology (2007) 0.98
Functional magnetic resonance imaging and c-Fos mapping in rats following an anorectic dose of m-chlorophenylpiperazine. Neuroimage (2006) 0.94
A robust experimental protocol for pharmacological fMRI in rats and mice. J Neurosci Methods (2011) 0.94
Methodological considerations in rat brain BOLD contrast pharmacological MRI. Psychopharmacology (Berl) (2005) 0.91
Pharmacological MRI in animal models: a useful tool for 5-HT research? Neuropharmacology (2008) 0.91
Assessing human 5-HT function in vivo with pharmacoMRI. Neuropharmacology (2008) 0.91
Lasting effects of chronic fluoxetine treatment on the late developing rat brain: age-dependent changes in the serotonergic neurotransmitter system assessed by pharmacological MRI. Neuroimage (2011) 0.88
Evidence that increased 5-HT release evokes region-specific effects on blood-oxygenation level-dependent functional magnetic resonance imaging responses in the rat brain. Neuroscience (2009) 0.83
5-HT(2C) antagonism blocks blood oxygen level-dependent pharmacological-challenge magnetic resonance imaging signal in rat brain areas related to feeding. Eur J Neurosci (2008) 0.82
Neuroadaptive responses to citalopram in rats using pharmacological magnetic resonance imaging. Psychopharmacology (Berl) (2010) 0.79
Mapping of brain activation in response to pharmacological agents using fMRI in the rat. Magn Reson Imaging (2001) 0.78
Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp (2010) 1.83
Differences in the evolution of the ischemic penumbra in stroke-prone spontaneously hypertensive and Wistar-Kyoto rats. Stroke (2009) 1.71
Cerebral impairment in chronic solvent-induced encephalopathy. Ann Neurol (2008) 1.45
Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp (2011) 1.40
Potential use of oxygen as a metabolic biosensor in combination with T2*-weighted MRI to define the ischemic penumbra. J Cereb Blood Flow Metab (2008) 1.35
White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors. Int J Radiat Oncol Biol Phys (2008) 1.30
Anaesthesia and physiological monitoring during in vivo imaging of laboratory rodents: considerations on experimental outcomes and animal welfare. EJNMMI Res (2012) 1.25
Molecular SPECT Imaging: An Overview. Int J Mol Imaging (2011) 1.18
Disturbed blood flow induces RelA expression via c-Jun N-terminal kinase 1: a novel mode of NF-κB regulation that promotes arterial inflammation. Circ Res (2011) 1.14
Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain (2008) 1.08
Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. PLoS One (2011) 1.01
A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology (2006) 0.96
Imaging technologies for preclinical models of bone and joint disorders. EJNMMI Res (2011) 0.94
Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender. Psychopharmacology (Berl) (2004) 0.93
Estrogen receptor beta agonist diarylpropiolnitrile (DPN) does not mediate neuroprotection in a rat model of permanent focal ischemia. Brain Res (2007) 0.92
Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology (2005) 0.92
Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type. Brain Imaging Behav (2015) 0.91
T₁ mapping detects pharmacological retardation of diffuse cardiac fibrosis in mouse pressure-overload hypertrophy. Circ Cardiovasc Imaging (2014) 0.91
Preliminary evidence of hippocampal damage in chronic users of ecstasy. J Neurol Neurosurg Psychiatry (2011) 0.91
Ecstasy in the brain: a model for neuroimaging. J Neuropsychiatry Clin Neurosci (2002) 0.89
Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment. Psychopharmacology (Berl) (2011) 0.89
Neurotoxic effects of ecstasy on the thalamus. Br J Psychiatry (2008) 0.88
Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. J Psychopharmacol (2006) 0.84
The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. Int J Methods Psychiatr Res (2005) 0.83
Haemodynamics in the mouse aortic arch computed from MRI-derived velocities at the aortic root. J R Soc Interface (2012) 0.83
Expression and localization of the mu-opioid receptor (MOR) in the equine cumulus-oocyte complex and its involvement in the seasonal regulation of oocyte meiotic competence. Mol Reprod Dev (2008) 0.80
Increase in central striatal dopamine transporters in patients with Shwachman-Diamond syndrome: additional evidence of a brain phenotype. Am J Med Genet A (2012) 0.78
Increased energy expenditure in gastric bypass rats is not caused by activated brown adipose tissue. Obes Facts (2012) 0.78
Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats. Eur Neuropsychopharmacol (2004) 0.77
White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy. AIDS (2016) 0.77
Neurologic abnormalities in HIV-1 infected children in the era of combination antiretroviral therapy. PLoS One (2013) 0.77
Heart rate reduction with ivabradine promotes shear stress-dependent anti-inflammatory mechanisms in arteries. Thromb Haemost (2016) 0.77
Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammation. Chem Commun (Camb) (2012) 0.77
The effects of ecstasy (MDMA) on brain serotonin transporters are dependent on age-of-first exposure in recreational users and animals. PLoS One (2012) 0.77
Correlation between clinical and histologic findings in the human neonatal hippocampus after perinatal asphyxia. J Neuropathol Exp Neurol (2014) 0.77
In vivo mapping of vascular inflammation using the translocator protein tracer 18F-FEDAA1106. Mol Imaging (2014) 0.76
How the aging brain translates motivational incentive into action: the role of individual differences in striato-cortical white matter pathways. Dev Cogn Neurosci (2011) 0.76
Correction: Effects of Chronic Fluoxetine Treatment on Neurogenesis and Tryptophan Hydroxylase Expression in Adolescent and Adult Rats. PLoS One (2015) 0.75
[Children with obesity and declining linear growth curve: Cushing's disease?]. Ned Tijdschr Geneeskd (2012) 0.75